Gene-sequencing technology developer Vision Medicals has completed a $30.9m round led by Tencent that took its total funding to approximately $74m.
Internet group Tencent has led a RMB200m ($30.9m) series C round for China-based gene-sequencing technology developer Vision Medicals, 36Kr reported yesterday.
Investment banking group China International Capital Corporation’s CICC Capital unit also participated in the round, as did CDH Investments, Volcanics Venture, and Cash Capital, an investment vehicle for Chinese Academy of Sciences Holdings.
Founded in 2018, Vision is developing gene sequencing and gene-editing technology as well as precision medicine used to diagnose and treat infectious diseases, utilising technologies such…